Research Overview
The available abstract-level evidence on yarrow (Achillea spp.) essential oil is limited and uneven, with the most attention directed toward gastrointestinal protection in experimental contexts. In particular, preclinical work has examined whether yarrow essential oil can mitigate ethanol-associated gastric mucosal injury (a common laboratory model of acute gastritis/ulceration). This focus aligns with broader pharmacological interest in plant essential oils as potential gastroprotective agents, typically assessed via outcomes such as ulcer index, macroscopic/microscopic mucosal damage, and markers related to oxidative stress and inflammation.
Across the abstracts provided, the strongest support is for a gastroprotective effect in ethanol-induced gastric injury models, suggesting yarrow essential oil may reduce the severity of ulceration under controlled experimental conditions. However, because the evidence base described is abstract-level and appears primarily preclinical, conclusions about clinical efficacy or safety in humans cannot be made. Key gaps include a lack of well-powered human studies, limited standardization of essential oil composition (which can vary substantially by species/chemotype, geography, and extraction method), and incomplete characterization of dose–response relationships and mechanisms of action.
Further research is needed to (i) replicate findings across independent laboratories and multiple ulcer models (not only ethanol-induced injury), (ii) identify active constituents and establish chemical standardization/quality control, (iii) evaluate pharmacokinetics, safety, and potential drug interactions, and (iv) conduct randomized controlled clinical trials to determine whether preclinical gastroprotective signals translate into meaningful benefits for people at risk of gastritis or peptic ulcer disease. Additional work on long-term toxicity and mucosal safety is particularly important given that essential oils can be biologically potent and may cause irritation or adverse effects at higher exposures.
1. What conditions has Yarrow Essential Oil been studied for?
Gastric ulcers / gastric mucosal injury (including ulceration associated with extreme ethanol ingestion).
2. Does it work in treating those conditions? Summarize the evidence.
The provided abstract-level information indicates that extreme ethanol ingestion is associated with developing gastric ulcers, but it does not include specific results showing that Yarrow Essential Oil prevents, treats, or heals ethanol-induced gastric ulcers.
Evidence of efficacy from the provided abstracts: Not determinable from the content supplied. The statement describes the condition (ethanol-associated ulcers) but does not report outcomes for Yarrow Essential Oil (e.g., ulcer index reduction, histology, mucus production, antioxidant markers, or comparison vs. control/standard therapy).
Conclusion: Based on the provided abstract information alone, there is insufficient evidence to conclude that Yarrow Essential Oil works for treating gastric ulcers.
3. What health benefits does it have?
From the provided abstract content, no direct health benefits of Yarrow Essential Oil are described or quantified.
Potential benefit area implied by the topic: Gastroprotection in the context of ethanol-induced gastric injury is a plausible research target, but the supplied text does not provide data demonstrating benefit.
Evidence-based conclusion: No specific health benefits can be confirmed from the provided abstract information.
4. Does it have any downsides or side effects?
The provided abstract content does not report adverse effects, toxicity findings, or safety outcomes for Yarrow Essential Oil.
Evidence from the provided abstracts: None reported regarding side effects or harms attributable to Yarrow Essential Oil.
What cannot be concluded: Whether Yarrow Essential Oil is safe at specific doses/routes (oral vs. topical vs. inhalation), whether it irritates gastric mucosa, or whether it interacts with medications—none of this is addressed in the supplied text.
5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?
No pharmacogenomic or gene–supplement interaction information is included in the provided abstract content.
Evidence from the provided abstracts: None.
Conclusion: No genetic variants can be identified as beneficial or harmful in relation to Yarrow Essential Oil based on the supplied information.
References
-
Achillea millefolium Essential Oil Mitigates Peptic Ulcer in Rats through Nrf2/HO-1 Pathway.
Manar K Alomair, Lama S Alabduladheem, Marwah A Almajed, Amjad A Alobaid, Essraa A R Alkhalifah, Nancy S Younis, Maged E Mohamed (2022) - Molecules (Basel, Switzerland)
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!